FATTY LIVER DISEASE
Clinical trials for FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New fatty liver drug enters first human tests
Disease control Recruiting nowThis early-stage study tests whether a new medicine called NNC4005-0001 is safe and tolerable for people with excess weight and fatty liver. About 60 adults will receive either the drug or a placebo, and the study lasts 7–8 months. The goal is to check for side effects and how th…
Matched conditions: FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
Could a common heart pill treat fatty liver?
Disease control Recruiting nowThis study tests whether a low dose of digoxin, a drug normally used for heart problems, can help people with a severe type of fatty liver disease called NASH (also known as MASH). About 144 adults with confirmed NASH and liver scarring will take digoxin or a placebo for a period…
Matched conditions: FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
15,000 Patients' records analyzed to uncover liver disease links
Knowledge-focused Recruiting nowThis study looks at medical records from 15,000 people with chronic liver diseases (like hepatitis, fatty liver, or cirrhosis) to understand how these conditions affect other body systems. Researchers will track new cases of liver cancer and serious liver complications over time.…
Matched conditions: FATTY LIVER DISEASE
Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC